超声与计算机断层扫描风险分层系统及活检标准在甲状腺癌术前患者颈部淋巴结中的验证
本回顾性研究纳入2006年12月至2015年6月间228例甲状腺癌术前患者共277枚颈部淋巴结,验证韩国甲状腺放射学会(KSThR)提出的超声与CT风险分层系统及活检标准。超声联合CT评估较单独超声降低了不确定淋巴结的比例(20.6%降至14.4%)及其恶性风险(31.6%降至12.5%),淋巴结大小不影响恶性风险,仅对可疑淋巴结进行活检的标准在保持敏感度的同时提高了特异度并降低了不必要的活检率。
要点
- 超声联合CT评估可减少不确定淋巴结比例及其恶性风险
- 淋巴结短径≤5 mm与>5 mm的恶性风险无显著差异
- 仅对可疑淋巴结活检的标准特异度更高且不必要活检率更低
核心结论
- 超声与CT联合评估有助于减少不确定淋巴结的比例及其中的恶性风险。
- 淋巴结大小不影响淋巴结的恶性风险,在所有影像学分类中均如此。
- 将不确定淋巴结纳入活检候选在所有影像学方法中均未显示出检测淋巴结转移的优势。
研究设计与样本
- 回顾性研究,纳入2006年12月至2015年6月间连续系列甲状腺癌术前患者228例,共277枚淋巴结。
- 患者均接受淋巴结活检、超声和计算机断层扫描(CT)检查。
- 淋巴结根据现行基于超声和CT的风险分层系统及KSThR建议的颈部淋巴结活检大小阈值分为可能良性、不确定或可疑。
诊断标准与关键数值
- 超声分类中,三类淋巴结的恶性风险差异显著(所有P < 0.001)。
- CT检测的可能良性与不确定淋巴结恶性风险相似且低(P = 0.468)。
- 超声联合CT标准对三类淋巴结的恶性风险分层显著(所有P < 0.001),并将不确定淋巴结比例从20.6%降至14.4%,其恶性风险从31.6%降至12.5%。
- 在所有影像学分类中,淋巴结短径≤5 mm与>5 mm的恶性风险无显著差异(P ≥ 0.177)。
- 仅针对可疑淋巴结的活检标准较现行标准在所有影像学方法中保持敏感度,同时特异度更高、不必要活检率更低。
临床应用与阅片要点
- 甲状腺癌术前评估中可联合超声与CT对颈部淋巴结进行风险分层。
- 淋巴结大小(短径≤5 mm vs >5 mm)不影响恶性风险,阅片时不应仅凭大小判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to validate the risk stratification system (RSS) and biopsy criteria for cervical lymph nodes (LNs) proposed by the Korean Society of Thyroid Radiology (KSThR).
MATERIALS AND METHODS: This retrospective study included a consecutive series of preoperative patients with thyroid cancer who underwent LN biopsy, ultrasound (US), and computed tomography (CT) between December 2006 and June 2015. LNs were categorized as probably benign, indeterminate, or suspicious according to the current US- and CT-based RSS and the size thresholds for cervical LN biopsy as suggested by the KSThR. The diagnostic performance and unnecessary biopsy rates were calculated.
RESULTS: A total of 277 LNs (53.1% metastatic) in 228 patients (mean age ± standard deviation, 47.4 years ± 14) were analyzed. In US, the malignancy risks were significantly different among the three categories (all P < 0.001); however, CT-detected probably benign and indeterminate LNs showed similarly low malignancy risks (P = 0.468). The combined US + CT criteria stratified the malignancy risks among the three categories (all P < 0.001) and reduced the proportion of indeterminate LNs (from 20.6% to 14.4%) and the malignancy risk in the indeterminate LNs (from 31.6% to 12.5%) compared with US alone. In all image-based classifications, nodal size did not affect the malignancy risks (short diameter [SD] ≤ 5 mm LNs vs. SD > 5 mm LNs, P ≥ 0.177). The criteria covering only suspicious LNs showed higher specificity and lower unnecessary biopsy rates than the current criteria, while maintaining sensitivity in all imaging modalities.
CONCLUSION: Integrative evaluation of US and CT helps in reducing the proportion of indeterminate LNs and the malignancy risk among them. Nodal size did not affect the malignancy risk of LNs, and the addition of indeterminate LNs to biopsy candidates did not have an advantage in detecting LN metastases in all imaging modalities.
引用
- Jeon YH, Lee JY, Yoo RE, et al. Validation of Ultrasound and Computed Tomography-Based Risk Stratification System and Biopsy Criteria for Cervical Lymph Nodes in Preoperative Patients With Thyroid Cancer. Korean J Radiol. 2023. PMID: 37634645. doi:10.3348/kjr.2023.0215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。